ArticleAnnals of hematology2023

Real world outcomes of lenalidomide or bortezomib maintenance in patients with multiple myeloma not undergoing stem cell transplantation.

Tianhong Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.